Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
(NASDAQ: GMAB) Delayed: 34.74 +0.21 (0.61%)
Previous Close $34.53    52 Week High $ 
Open $34.92    52 Week Low $ 
Day High $35.15    P/E N/A 
Day Low $34.72    EPS $ 
Volume 2,711,563       

(NASDAQ: GMAB) Delayed: 34.74 +0.21 (0.61%)
Previous Close $34.53    52 Week High $ 
Open $34.92    52 Week Low $ 
Day High $35.15    P/E N/A 
Day Low $34.72    EPS $ 
Volume 2,711,563